Premium commercial manufacturing and ADCs. Compare Swissmedic-regulated Swiss CDMOs across biologics, ADCs, and high-value drug product — by capability and site.
Switzerland punches far above its size in pharmaceutical manufacturing. It is home to major CDMO headquarters and a concentration of premium, commercial-scale capacity — biologics, antibody-drug conjugates (ADCs), and high-value complex products — backed by an exceptional quality and engineering talent pool around Basel.
Swissmedic is a rigorous regulator with mutual recognition arrangements that align Swiss GMP with EU, FDA, and other major authorities. For high-value commercial programs where quality and reliability outweigh headline cost, Switzerland is a destination of choice.
The Basel corridor in particular is one of the world's densest life-science clusters, with deep ADC and biologics expertise. Swiss CDMOs command premium pricing, justified for late-stage and commercial products where supply reliability and quality systems are decisive.
No companies found in this category yet. Check back soon.
Browse all CDMOsHow this list is built: companies appear here when they have a manufacturing site in Switzerland in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Our AI Matchmaker analyzes your project requirements and matches you with qualified Switzerland manufacturing partners. Free for buyers.